throbber
1
`
`3M COMPANY 2005
`Mylan Pharmaceuticals Inc. v. 3M Company
`IPR2015-02002
`
`

`
`2
`
`

`
`have become the most predominant.
`Terbutaline sulfate, albuterol, meta-
`proterenol sulfate, ipratropium bro-
`mide, beclomethasone diproprionate,
`flunisolide and disodium cromoglycate
`are common examples of drugs deliv-
`ered in this type of
`formulation.
`Suspension type MDIs are likely to
`remain popular,
`since the much
`forecast replacement of dichlorodi-
`fluoromethane (CFC-12) by 1,1,1,2
`tetrafluoroethane (HFC-134a)* is like-
`ly to produce propellants with even
`less drug solubilizing potential than
`those in use today. The advantages of
`suspension type MDIs are:
`A. Wide Applicability—No minimum
`solubility is required, though it is prob-
`able that Ostwald ripening will be a prob-
`lem if the drug exhibits “significant”
`solubility in the propellant, but not
`enough to allow its formulation as a high
`volatility solution aerosol.
`B. Improved Chemical Stability-
`Drug remains in the solid phase, reduc-
`ing the probability of chemical degrada-
`tion.
`C. Relatively large doses of drugs can
`be delivered per actuation—For example,
`Intal"’ MDI (Fisons) delivers 5mg of
`disodium cromoglycate per shot.
`Unfortunately,
`suspension type
`MDIs have some disadvantages asso-
`ciated with them:
`A. Reduced Physical Stability—Sus-
`pended drug particles have a tendency
`to either sink or float unless their densi-
`ty exactly matches that of the pro-
`pellant. This potentially causes two
`problems:
`1. Unreproducible dose delivery can
`result from delays between shaking
`and firing the MDI.
`2. Patients must vigorously shake
`the MDI before use.
`B. Sub-optimal Respirable Fraction-
`The size of the resulting aerosol cannot
`be less than the size of the primary par-
`ticles used in its manufacture. Solution
`aerosols can theoretically produce in-
`finitely small particles.
`C. Suspension type MDIs are more
`complex to manufacture than solution
`MDIs.
`"
`D. Higher Propellant Leakage Rate-
`High concentration suspension type
`MDIs are potentially problematic due to
`drug particles preventing proper valve
`Operation.
`
`In order to produce a robust. ef-
`ficacious product, the MDI formulator
`Should consider several factors during
`
`'Editor's note: A discussion of potential phar-
`maceutical propellants in light of the CFO phase-
`°“t can be found in the August 1990 issue of
`Aenosot Ace.
`in the cover story “A Status
`R5901? CF'C’s in Pharmaceutcal Aerosols," by
`Tfilmuce M. Coyne.
`
`the course of product development.
`Some of these are common to both
`types of MDI formulation, for exam-
`ple: chemical stability of the drug,
`uniformity of dose, total number of
`doses per unit, packaging component
`compatibility and extractables from
`valve elastomers. However, several
`factors are specifically of interest in
`the formulation of suspension type
`MDIs:
`
`the
`
`A. Starting particle size of
`primary drug particles.
`B. Crystal growth of the primary drug
`particles in the liquefied propellant.
`C. Sedimentation of primary drug par-
`ticles in the liquefied propellant.
`D. Flocculation of primary drug par-
`ticles in the liquefied propellant.
`E. Effect of sedimentation and floc-
`culation on dose uniformity.
`F. Effect of suspension concentration
`
`Figure 2. Appearance of several experimental MDI formulations. (left to right) 0.25,
`0.5, 1, 2, 5, and 60 minutes following shaking. (A) 1%w/v drug. 0.5°/ow/w sorbitan
`trioleate in 60%w/w CFC-12 and 40%w/w CFC-114: (Bl 1%w/v drug, 0.5%w/w sor-
`bitan triolaate in CFC-12; (C) 1%w/v drug. 0.5%w/w soya lecithin in CFC-12. Courtesy
`of Fisons Pharmaceutical Division.
`
`V - AEROSOL AGE, October 1990
`L
`
`3
`
`23
`
`

`
`4
`
`

`
`5
`
`

`
`6
`
`

`
`7
`
`

`
`Aerosol
`
`Services
`Company, Inc.
`
`THE West Coast Contract Packager:
`
`For Service (‘all
`818—968-8531
`
`llil
`
`co-.cs-<,-tmcim:
`
`‘B
`
`Emu» m,:».«
`
`425 So. Ninth Avenue /City of Industry, California 91746
`Circle Reader’s Service Card No. 155
`
`AEROSOLS -
`
`& LIQUIDS
`CONFIDENCE
`Drug licensed, quality control
`per GMP, computerized
`materials control, complete
`laboratory facilities and staff.
`
`SERVICE
`Full compounding facilities,
`six flexible filling lines,
`including a clean room and
`a professional staffat
`your service.
`
`~
`0
`
`Your Source For
`
`Table Four
`
`AEROSOL
`EQUIPMEN4
`
`.
`
`.
`
`.
`
`..
`
`Mexican Productions for 1989 and 1990 (est.l,
`b Product Cate or
`
`Category
`Personal Products
`Insecticides
`Household Products
`Industrial Products
`Paints
`Medical Products
`
`1989
`17.1MM
`14.9
`5.0
`45
`4.6
`3.0
`
`1990 (est.); Er percentages
`17.9MM
`34%
`15.2
`29
`5.3
`10
`4.7
`9
`5.2
`10
`3.7
`7
`
`quet, tennis and domino tournaments
`and other opportunities for communi«
`cation. Some of the most magnificent
`prehistoric ruins in the Western Hemi-
`sphere are within a 90 minute drive
`from Cancun. They include the mile-
`square archeological site of Chichen
`Itza, where an estimated 12,000
`virgins were thrown into a huge well
`with unscalable limestone walls, the
`famous ruins of Tulum, with the main
`pyramid and altar built overlooking
`the Caribbean, and even a small min on
`Cancun itself. Many of the delegates
`brought their families and stayed two
`or three extra days in order to see and
`enjoy this picturesque Mayan area of
`Mexico, some 1200 miles by road from
`Mexico City. All in all, this was a con-
`
`vention to be remembered, sparked by
`the vigor and confidence of the Mex-
`ican aerosol industry as they move for-
`ward into the 19903. u
`
`consulting on
`aerosols
`
`litigation services
`
`patents
`
`special services
`
`Walter C. Beard, Inc.
`Middlebury, Conn. 06762 U.S.A.
`208-758-2194 - Cable WCBI
`Fax: 203-598-3243
`
`We Are Exclusive
`East Coast Representatives For:
`TERCO, INC.
`Aerosol arid Bairicr Pkltilx I.iiios
`Tippers. O\‘err:iippei‘s. Cliziiigii Parts
`Pro-I*‘al)ric:ale(l (lzissiiig Hriuses
`o
`ENGINEERED Al.l'l'(‘)MATION. INC.
`Piickers. Dc-l’iic:l\’ers
`Custom Assiiiiibly Eqiiipiiiuiil
`0
`ANODE PRODUCTS COMPANY. INC.
`VVt1lPl' Balli Filtrnlioii Sysltriiis
`0
`From Pilot Plants to High Spocil
`Lilies. (ioiitarzt Us for a
`Fast. Kiirm'le(l_L;eal)le Rospoiise—
`Canada to Florirla
`Cz\I.L
`DOUG or DON BE.i\RDSV\'UR'l'H
`(203) 253-4011
`D. A. BEARDSWORTII ASSOCIATES. INC.
`660 Main St. South #3/‘Box 686
`Wuodbury, CT 06798
`
`Circle Reader's Service Card No. 156
`
`Trust Our Name
`
`Piedmont Laboratories is building a reputation as a
`quality contract packager on superior product and
`customer service that really cares.
`We have a large. new facility located in the beautiful
`rolling countryside outside of Atlanta, Georgia, and
`welcome your visit and the opportunity to talk about
`yourfilling needs.
`Our dedicated lines for household, auto. industrial and
`personal products are licensed by the EPA and FDA and
`equipped to fill all types of barrier cans.
`
`PIEDMONT
`
`LABORATORIES
`Specizilists in (,,‘.niiri'-act P:lCl(k1,Ll,lltl_[ nfAci'nsols ziml Liqiiiils.
`
`2030 Old Candler Road, Gainesville, Georgia 30501
`(404) 5340300 TELEX 54307 FAX (404)535-8132
`
`Circle ‘Reader’s Service Card No. 157
`
`8
`
`AEROSOL AGE, October 1990
`
`

`
`0 Contract
`Packaging
`0 Custom
`
`Formulation
`
`CONTACT:
`
`PAUL HOLBFIOOK
`713-444-6454
`
`AEROSOLS V/JJQUIDS
`0 Insecticides “~‘ Household
`
`0 Toiletries
`
`Circle Reader's Service Card No. 159
`
`I
`
`I
`
`IHN Geciren & nssocmres
`Consultants to the
`Chemical Industry
`7 Snourdon, Dove Conuon, (R 92679
`(714) 589-6233 - FR)! (7I4) 58945271
`
`Particle Size Analysers
`stop-action laser holography
`0 Size Distribution
`0 Concentration
`- Shape
`Laboratory Testing Service
`Custom Designed Systems
`(815) 389-2136
`olllrler PHDTDGRAPHIC LABDRATEIRIEEI
`1120 Manchester Rd.
`Since
`1972
`South Beloit,
`II. 51080
`
`
`
`Circle Reader's Service Card No. 153
`
`Metered Dose Inhalers
`Begins on page 22
`
`light some of the pitfalls that may be
`encountered during the formulation,
`scale-up and manufacture of suspen-
`sion type metered dose inhalers. In
`order to produce an elegant, safe, and
`efficacious product
`the formulator
`should try to minimize apparently
`trivial idiosyncracies associated with
`the formulation. The additive effect of
`these “minor" problems can conspire
`to prevent; commercialization of an
`otherwise effective drug. These chal-
`lenges are likely to increase over the
`coming years since formulators will be
`presented with alternatives to CFC
`propellants, with which they have lit-
`tle experience. H
`
`Acknowledgement
`I would like to thank Fisons Pharmaceutical Divi-
`sion, Lougnoorough, England, for granting me per-
`mission to present data generated while I was
`employed there. Specifically,
`I am indebted to: Clive
`Booles, Lynn Brown. Andy Ludzig. Janet Mldgley.
`Steve NlCli0lS, Phil Warrington and Paul Wright.
`
`20 MM.
`BOTTLE CHIMPING
`HEADS
`tolerances than
`to lighter
`Manulaclureil
`anything on the market - at approximately
`113 lower cost. Try one lor sixty days
`— If It Is not Ihe BEST crimping head you have ever used,
`andior does NOT corracl your crimping problems - relurn
`ll llJ IIS M IIII GDSI.
`Please call Ior a crimping head on a trial basis andlor
`technical information.
`
`MENTON ENGINEERING C0.
`103 Old Colony Ave.
`P.0. Box 452
`E. Taunlan. MA 02718
`‘ Phone 1-508-824-3061
`
`Do you have obsolete Lithographed cans
`that are taking up valuable warehouse space?
`We have been turning unwanted obsolete lilhographecl con-
`tainers into saleable usable containers for many satisfied
`customers for the last 15 years—wheIher your obsoleies are triple-
`tites, aerosols or cone tops we can strip the lithography from these
`cons, quickly and economically without altering the physical pro-
`periies of the cans.
`
`We will buy your obsoletes or clean
`and return them to you, call us today.
`Joe or Mark Gregory
`
`I.I1'HO-OFF CORPORATION
`402 E. Roosevelt
`Wheaten, II. 60I 87
`
`Circle Readers Service Card No. 164
`
`Circle Reader’s Service Card No. 165
`
`AEROSOL AGE, October 1990
`k_
`
`9
`
`89
`
`0 Automotive CSA LIMITED, INC. F’.O. Box 690347/ Houston, Texas 77269-0347
`404-534-5171
`(203) 877-4151
`(708) 653-7979
`
`ENGINEERS AND TECHNICIANS
`
`Specializing in Aerosol and Liquid
`Filling Technology
`—Engineering Design and Project
`Management
`—Custom Machinery and Modifications
`—Turnkey Projects
`—Troub|e shooting
`—Training Programs
`H. WILLIAMS ASSOCIATES
`P.0. Box 907342 Northlake Station
`Gainesville, GA 30501-0906
`
`Circle Reader’s Service Card No. 162
`
`AEROSOLS
`NEW PRODUCT
`DEVELOPMENT Consultant
`PACKAGING
`LITIGATION
`PATENTS
`FORMULATION
`PRODUCTION
`PROBLEMS
`
`PO. Box 3397
`Milford, CT 06460
`
`Circle Reader's Service Card No. 163
`
`
`
`CONSULTING ON:
`- EPA/CPSC/OSHA/DOT/FDA Compliance
`0 Aerosol/Liquid Product Development
`- Custom Formulating &_ Packaging
`- Quality & Environmental Auditing
`' Operations Trouble Shooting
`0 Litigation Services
`
`Circle Reader’s Service Card No. 160
`
`BRUCE NELSON CUMPANY
`
`Project Engineering and New
`Product Development
`Product Liability Intervention
`& 24 hr. Hot-line service “800”
`
`Litigation Services and
`Product Failure analysis
`0 Lab and aerosol equipment
`- Quality & Safety auditing
`
`Box 674, W. Yarmouth, MA 02673
`tel. or fax 508-771-3607
`Circle Reader’s Service Card No. 161

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket